SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Pulmatrix, Inc. (PULM) (CIK 0001574235) (PULM) — Aug 1, 2016

Pulmatrix, Inc. (PULM) (CIK 0001574235)
Date: Aug. 1, 2016 · CIK: 0001574235 · Accession: 0001193125-16-666314

AI Filing Summary & Sentiment

File numbers found in text: 333-212546

Date
August 1, 2016
Author
Not clearly detected
Form
CORRESP
Company
Pulmatrix, Inc. (PULM) (CIK 0001574235)

Letter

Pulmatrix, Inc.

99 Hayden Avenue | Suite 390

Lexington, MA 02421

August 1, 2016

VIA EDGAR AND FACSIMILE

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, D.C. 20549

Attn: Ms. Suzanne Hayes

Re: Pulmatrix, Inc.

Registration Statement on Form S-3, originally filed on July 15, 2016

File No. 333-212546, as amended (the “Registration Statement”)

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Pulmatrix, Inc. (the “Company”) hereby respectfully requests acceleration of the effective date of the Registration Statement so that it may become effective at 4:30 p.m., Eastern Time, on August 3, 2016, or as soon thereafter as practicable.

In connection with the Company’s request for acceleration of the effective date of the Registration Statement, the Company acknowledges the following:

•

should the U.S. Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

•

the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

•

the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Haynes and Boone, LLP, attention: Rick A. Werner, Esq. at (212) 659-4974.

Very truly yours,
Pulmatrix, Inc.

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 Pulmatrix, Inc.

99 Hayden Avenue | Suite 390

Lexington, MA 02421

 August 1, 2016

 VIA EDGAR AND FACSIMILE

 U.S. Securities and
Exchange Commission

 Division of Corporation Finance

 100 F
Street, NE

 Washington, D.C. 20549

 Attn: Ms. Suzanne
Hayes

Re:
Pulmatrix, Inc.

 Registration Statement on Form S-3, originally filed on July 15, 2016

 File No. 333-212546, as amended (the “Registration Statement”)

Ladies and Gentlemen:

 Pursuant to Rule 461
promulgated under the Securities Act of 1933, as amended, Pulmatrix, Inc. (the “Company”) hereby respectfully requests acceleration of the effective date of the Registration Statement so that it may become effective at 4:30
p.m., Eastern Time, on August 3, 2016, or as soon thereafter as practicable.

 In connection with the Company’s request for
acceleration of the effective date of the Registration Statement, the Company acknowledges the following:

•

should the U.S. Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from
taking any action with respect to the filing;

•

the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the
disclosure in the filing; and

•

the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

 Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact
our counsel, Haynes and Boone, LLP, attention: Rick A. Werner, Esq. at (212) 659-4974.

 Very truly yours,

 Pulmatrix, Inc.

 By:

 /s/ Robert W. Clarke, Ph.D.

Robert W. Clarke, Ph.D.

Chief Executive Officer